This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
General Electric Take Multiple Debt Restructuring Actions
by Zacks Equity Research
General Electric (GE) commences multiple actions to strengthen its financial positions. Proceeds from the BioPharma divestment and new debt offerings have been used for reducing leverage.
Danaher Gives Update on Q1 Results, Withdraws 2020 Guidance
by Zacks Equity Research
Danaher (DHR) provides an update on first-quarter 2020 results and withdraws its earlier announced guidance for 2020 on the impacts of the coronavirus outbreak.
Coronavirus-Led Upheaval Puts 4 Jet Engine Makers in Trouble
by Aparajita Dutta
To cope up with the economic impacts of coronavirus outbreak, airline companies are taking initiatives like delaying deliveries of new jets. In a ripple effect, jet engine makers are bearing the brunt.
General Electric Withdraws 2020 View on Coronavirus Concerns
by Zacks Equity Research
General Electric (GE) suspends 2020 projections on uncertainties related to the coronavirus outbreak. Also, earnings in the first quarter are expected to be weaker than previously expected.
Danaher (DHR) Prices Senior Notes Offering Worth Euro 750M
by Zacks Equity Research
Danaher (DHR) prices euro 750 million worth of senior notes offerings. The net proceeds will be used for satisfying generate corporate purposes, including repaying debts.
Raytheon Technologies Begin Trading as Merger of Equals Closes
by Zacks Equity Research
Raytheon Technologies (RTX) is born as United Technologies' aerospace business and Raytheon Company combine. The resultant company will be one of the big players in the defense and government markets.
Danaher Closes Buyout of General Electric's BioPharma Business
by Zacks Equity Research
Danaher (DHR) completes the acquisition of General Electric's BioPharma business. The buyout will likely strengthen the company's biologics workflow solutions business.
General Electric Closes Divestment of BioPharma to Danaher
by Zacks Equity Research
General Electric (GE) completes the divestment of its BioPharma business to Danaher. The net proceeds received from the transaction will be used by General Electric to lower its debt burden.
General Electric (GE) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, General Electric (GE) closed at $7.92, marking a +0.38% move from the previous day.
The Zacks Analyst Blog Highlights: General Electric, Ford, 3M, Vir and Biogen
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Electric, Ford, 3M, Vir and Biogen
Diverse Companies Join Forces to Fight Coronavirus Menace
by Payal Jalan
Nervousness related to the coronavirus outbreak is visible across the economies worldwide. Amid the pandemic, many corporates have come together to help contain the outbreak.
3D Printing Firms Join Fight Against Coronavirus-Led Disaster
by Chandrima Sanyal
Here, we discuss the efforts of additive manufacturing companies to improve safety for healthcare workers with 3D-printed materials.
The Zacks Analyst Blog Highlights: Walt Disney, General Electric, Fiserv, S&P Global and TJX Companies
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walt Disney, General Electric, Fiserv, S&P Global and TJX Companies
Danaher (DHR) Prices Euro 1.75B Worth Senior Notes Offering
by Zacks Equity Research
Danaher (DHR) prices euro 1.75 billion worth of senior notes offerings. The net proceeds will be used for satisfying generate corporate purposes, including repaying debts.
Conglomerates Accelerate Efforts to Fight Coronavirus Menace
by Avisekh Bhattacharjee
Several industrial conglomerates including General Electric (GE), Honeywell (HON), Danaher (DHR) and 3M (MMM) are increasing steps to mitigate the effects of the coronavirus menace.
Top Research Reports for Disney, General Electric & Fiserv
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney (DIS), General Electric (GE) and Fiserv (FISV).
Join the Wall Street Rally With Industrial ETFs
by Sanghamitra Saha
The industrial sector contributed to the colossal rally at Wall Street on Mar 24 on the hopes of deal wins and a slew of good news from the space.
4 Stocks Bucking the Layoff Trend Amid Coronavirus Scare
by Suranjana Roy
COVID-19 is taking an enormous toll on economic and health infrastructure, thereby resulting in massive layoffs. However, there are certain companies that are challenging this downtrend.
General Electric Announces Coronavirus' Impacts on Its Business
by Zacks Equity Research
General Electric's (GE) aviation segment seeks to lower the U.S. workforce by 10% on coronavirus concerns. The company announces various other measures to deal with the impact of the outbreak.
Danaher to Soon Close BioPharma Buyout, Receives FTC Approval
by Zacks Equity Research
Danaher (DHR) receives a go-ahead for the acquisition of GE's BioPharma business. The buyout will likely strengthen its biologics workflow solutions business.
Yes, You Can Time the Market. Find out How - March 20, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
General Electric (GE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
General Electric (GE) closed the most recent trading day at $6.48, moving -1.82% from the previous trading session.
GE to Offer Wind Turbine Solution to Sanko Enerji in Turkey
by Zacks Equity Research
General Electric's (GE) Cypress wind turbines are likely to make Guney wind farm in Turkey efficient in producing clean energy and cater to the increasing demand for electricity.
Lockheed Martin (LMT) Wins Deal to Deliver 50 C-130J Parts
by Zacks Equity Research
Lockheed Martin (LMT) is going to deliver 14 enhanced center wing boxes and 14 component kits in relation to the C-130J center wing box replacement program.
Danaher (DHR) Poised to Gain From Buyouts Despite Cost Woes
by Zacks Equity Research
Danaher (DHR) to gain from synergistic benefits from acquired assets as well as innovation efforts and shareholder-friendly policies. High costs and debts along with forex woes might be dragging.